Related Experiment Video
Updated: Apr 18, 2026

Author Spotlight: Investigating the Pathophysiology of Eosinophilic Esophagitis
Published on: May 10, 2024
Association of Serum Eosinophilic Cationic Protein With Disease Severity in Infant Bronchiolitis
Selcen Bedir1, Yılmaz Seçilmiş2
1Department of Pediatrics.
Insights
Serum eosinophilic cationic protein (ECP) did not diagnose bronchiolitis but showed higher levels in severe cases and with tobacco smoke exposure. ECP may reflect inflammatory phenotypes, not predict severity independently.
Area of Science:
- Pediatric Respiratory Medicine
- Clinical Immunology
- Biomarker Research
Background:
- Acute bronchiolitis is a common respiratory infection in infants.
- Identifying reliable biomarkers for disease severity is crucial for clinical management.
- Tobacco smoke exposure is a known risk factor for respiratory illnesses.
Purpose of the Study:
- To evaluate serum eosinophilic cationic protein (ECP) levels in children with acute bronchiolitis versus healthy controls.
- To investigate the association of serum ECP with clinical severity and tobacco smoke exposure.
- To assess ECP's potential as a diagnostic or prognostic biomarker.
Main Methods:
- Prospective cross-sectional study of 96 infants with bronchiolitis and 96 controls (1-24 months).
- Serum ECP levels and routine labs measured; associations with severity indicators (ICU admission, ventilation) and smoke exposure analyzed.
- Multivariable logistic regression used to identify predictors of severe bronchiolitis.
Main Results:
- Serum ECP levels did not differ between bronchiolitis patients and controls.
- Higher ECP levels were found in severe cases (ICU admission, ventilation) and with tobacco smoke exposure.
- ECP correlated with leukocyte counts and glucose; tobacco smoke exposure was an independent predictor of severity.
Conclusions:
- Serum ECP lacks independent prognostic utility for acute bronchiolitis.
- Elevated ECP in severe, smoke-exposed cases suggests it reflects inflammatory phenotypes.
- ECP is not a direct clinical risk stratification tool for bronchiolitis severity.
Objectives:
This study aimed to evaluate serum eosinophilic cationic protein (ECP) levels in young children with acute bronchiolitis compared with healthy controls and to investigate their association with clinical severity and tobacco smoke exposure. We hypothesized that ECP would not function as a diagnostic biomarker but might reflect inflammatory phenotypes associated with severe disease.
Methods:
In this prospective cross-sectional study, 96 children aged 1 to 24 months with acute bronchiolitis and 96 age-matched and sex-matched healthy controls were enrolled. Serum ECP levels and routine laboratory parameters were measured at presentation. Within the bronchiolitis cohort, associations between serum ECP levels and clinical severity indicators-including oxygen requirement, ICU admission, mechanical ventilation, and prenatal or passive tobacco smoke exposure-were evaluated. Correlations between ECP and systemic inflammatory markers were analyzed using Spearman correlation analysis. Multivariable binary logistic regression was performed to identify independent predictors of severe bronchiolitis.
Results:
Serum ECP levels did not differ significantly between young children with bronchiolitis and healthy controls, indicating limited diagnostic utility. However, within the bronchiolitis group, significantly higher ECP levels were observed in young children requiring ICU admission or mechanical ventilation and in those with prenatal or passive tobacco smoke exposure. Serum ECP levels demonstrated significant positive correlations with total leukocyte count and leukocyte subpopulations, including neutrophils, monocytes, and eosinophils, as well as with serum glucose levels. Age-stratified analyses revealed distinct leukocyte profiles across infancy, whereas serum ECP concentrations remained comparable between age groups. In multivariable analysis adjusting for age and tobacco smoke exposure, serum ECP was not independently associated with severe disease, whereas tobacco smoke exposure emerged as a strong independent predictor of severe bronchiolitis.
Conclusions:
Although serum ECP does not seem to have independent prognostic utility, its elevation in severe and smoke-exposed cases suggests that it may reflect distinct inflammatory phenotypes in bronchiolitis rather than function as a direct clinical risk stratification tool.
Related Concept Videos
Asthma I: Introduction
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Asthma III: Clinical Manifestations
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...

